Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gadobutrol Dose Comparison MRI Study in CNS Diseases
NCT00862459Phase 2Completed
- Sponsor
- Bayer
- Start
- Aug 2005
- Primary completion
- Mar 2007
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 2, randomised, double-blind trial of gadobutrol in Brain diseases and Spinal Cord Abnormalities (3 arms), sponsored by Bayer. Primary endpoints: Categorical Visualization Score, Difference in Number of Lesions Detected and 4 more. Started Aug 2005; status: completed.
02
Drugs
gadobutrol
03
Conditions
Brain diseasesSpinal Cord Abnormalities
Beyond the preview
Go deeper on NCT00862459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00862459.